

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | lipopolysaccharide biosynthetic process (GO:0009103) | 6.60611547 |
| 2 | DNA methylation involved in gamete generation (GO:0043046) | 6.31281638 |
| 3 | protein-chromophore linkage (GO:0018298) | 6.20177723 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.91830551 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 5.91830551 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.83183129 |
| 7 | L-phenylalanine catabolic process (GO:0006559) | 5.83183129 |
| 8 | lipopolysaccharide metabolic process (GO:0008653) | 5.75310065 |
| 9 | meiotic chromosome segregation (GO:0045132) | 5.67937841 |
| 10 | protein retention in ER lumen (GO:0006621) | 5.61278047 |
| 11 | sulfate transmembrane transport (GO:1902358) | 5.44683391 |
| 12 | GDP-mannose metabolic process (GO:0019673) | 5.30663128 |
| 13 | * sphingosine metabolic process (GO:0006670) | 5.29718734 |
| 14 | regulation of odontogenesis of dentin-containing tooth (GO:0042487) | 5.15252918 |
| 15 | proline biosynthetic process (GO:0006561) | 5.12566497 |
| 16 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 5.08595009 |
| 17 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 5.07903272 |
| 18 | iron coordination entity transport (GO:1901678) | 5.00234002 |
| 19 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.99724418 |
| 20 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.88947712 |
| 21 | cellular response to ATP (GO:0071318) | 4.77653571 |
| 22 | aromatic amino acid family catabolic process (GO:0009074) | 4.70826998 |
| 23 | * diol metabolic process (GO:0034311) | 4.67254995 |
| 24 | sulfate transport (GO:0008272) | 4.63625533 |
| 25 | paraxial mesoderm development (GO:0048339) | 4.61824712 |
| 26 | piRNA metabolic process (GO:0034587) | 4.61528600 |
| 27 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 4.52817134 |
| 28 | sulfur amino acid catabolic process (GO:0000098) | 4.51040776 |
| 29 | alpha-linolenic acid metabolic process (GO:0036109) | 4.35831492 |
| 30 | proline metabolic process (GO:0006560) | 4.34406226 |
| 31 | protein carboxylation (GO:0018214) | 4.29463261 |
| 32 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.29463261 |
| 33 | regulation of triglyceride catabolic process (GO:0010896) | 4.28596554 |
| 34 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 4.26431723 |
| 35 | urea cycle (GO:0000050) | 4.23327039 |
| 36 | urea metabolic process (GO:0019627) | 4.23327039 |
| 37 | plasma lipoprotein particle clearance (GO:0034381) | 4.20799489 |
| 38 | cysteine metabolic process (GO:0006534) | 4.20723600 |
| 39 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.19142811 |
| 40 | phospholipid efflux (GO:0033700) | 4.15240320 |
| 41 | high-density lipoprotein particle remodeling (GO:0034375) | 4.10175150 |
| 42 | glyoxylate metabolic process (GO:0046487) | 4.10059544 |
| 43 | * sphingoid metabolic process (GO:0046519) | 4.08115929 |
| 44 | regulation of cholesterol homeostasis (GO:2000188) | 4.07297594 |
| 45 | regulation of synapse structural plasticity (GO:0051823) | 4.04410592 |
| 46 | DNA strand renaturation (GO:0000733) | 4.03716359 |
| 47 | regulation of protein glycosylation (GO:0060049) | 4.02296232 |
| 48 | kynurenine metabolic process (GO:0070189) | 4.00981629 |
| 49 | bile acid biosynthetic process (GO:0006699) | 3.99679668 |
| 50 | positive regulation of developmental pigmentation (GO:0048087) | 3.91335124 |
| 51 | nitrogen cycle metabolic process (GO:0071941) | 3.89892151 |
| 52 | regulation of cholesterol esterification (GO:0010872) | 3.88933507 |
| 53 | complement activation, alternative pathway (GO:0006957) | 3.88670369 |
| 54 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.87445427 |
| 55 | negative regulation of glycoprotein metabolic process (GO:1903019) | 3.85896164 |
| 56 | negative regulation of fibrinolysis (GO:0051918) | 3.85735117 |
| 57 | vitamin transmembrane transport (GO:0035461) | 3.85492119 |
| 58 | adenosine receptor signaling pathway (GO:0001973) | 3.84579942 |
| 59 | tryptophan catabolic process (GO:0006569) | 3.82482256 |
| 60 | indole-containing compound catabolic process (GO:0042436) | 3.82482256 |
| 61 | indolalkylamine catabolic process (GO:0046218) | 3.82482256 |
| 62 | phosphatidylglycerol biosynthetic process (GO:0006655) | 3.82263121 |
| 63 | pantothenate metabolic process (GO:0015939) | 3.81586628 |
| 64 | intestinal cholesterol absorption (GO:0030299) | 3.78873550 |
| 65 | negative regulation of cholesterol transport (GO:0032375) | 3.78313076 |
| 66 | negative regulation of sterol transport (GO:0032372) | 3.78313076 |
| 67 | regulation of meiosis I (GO:0060631) | 3.70430124 |
| 68 | regulation of fibrinolysis (GO:0051917) | 3.69035209 |
| 69 | reverse cholesterol transport (GO:0043691) | 3.66920227 |
| 70 | flavonoid metabolic process (GO:0009812) | 3.61257960 |
| 71 | serine family amino acid catabolic process (GO:0009071) | 3.60793171 |
| 72 | tryptophan metabolic process (GO:0006568) | 3.60398642 |
| 73 | plasma lipoprotein particle assembly (GO:0034377) | 3.60146564 |
| 74 | regulation of protein activation cascade (GO:2000257) | 3.58319375 |
| 75 | mannose metabolic process (GO:0006013) | 3.58054347 |
| 76 | sulfur compound transport (GO:0072348) | 3.57691968 |
| 77 | negative regulation of cell aging (GO:0090344) | 3.57115569 |
| 78 | notochord development (GO:0030903) | 3.56621059 |
| 79 | bile acid metabolic process (GO:0008206) | 3.56520375 |
| 80 | cholesterol efflux (GO:0033344) | 3.56479255 |
| 81 | regulation of skeletal muscle contraction (GO:0014819) | 3.55985464 |
| 82 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.55556126 |
| 83 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.55556126 |
| 84 | homocysteine metabolic process (GO:0050667) | 3.54978226 |
| 85 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.54273901 |
| 86 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.53999432 |
| 87 | ethanol oxidation (GO:0006069) | 3.48981178 |
| 88 | cellular modified amino acid catabolic process (GO:0042219) | 3.48568756 |
| 89 | trivalent inorganic anion homeostasis (GO:0072506) | 3.47504000 |
| 90 | phosphate ion homeostasis (GO:0055062) | 3.47504000 |
| 91 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 3.47251650 |
| 92 | triglyceride homeostasis (GO:0070328) | 3.46367977 |
| 93 | acylglycerol homeostasis (GO:0055090) | 3.46367977 |
| 94 | protein-lipid complex remodeling (GO:0034368) | 3.45628874 |
| 95 | macromolecular complex remodeling (GO:0034367) | 3.45628874 |
| 96 | plasma lipoprotein particle remodeling (GO:0034369) | 3.45628874 |
| 97 | amino-acid betaine metabolic process (GO:0006577) | 3.45542262 |
| 98 | protein-lipid complex assembly (GO:0065005) | 3.45022261 |
| 99 | aromatic amino acid family metabolic process (GO:0009072) | 3.41006133 |
| 100 | ethanol metabolic process (GO:0006067) | 3.39817558 |
| 101 | regulation of complement activation (GO:0030449) | 3.37507050 |
| 102 | regulation of pigment cell differentiation (GO:0050932) | 3.36540798 |
| 103 | cholesterol homeostasis (GO:0042632) | 3.36363552 |
| 104 | nodal signaling pathway (GO:0038092) | 3.35353004 |
| 105 | positive regulation of lipid catabolic process (GO:0050996) | 3.33550404 |
| 106 | SMAD protein complex assembly (GO:0007183) | 3.33051316 |
| 107 | low-density lipoprotein particle clearance (GO:0034383) | 3.32032726 |
| 108 | sterol homeostasis (GO:0055092) | 3.30976768 |
| 109 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.30625685 |
| 110 | DNA damage induced protein phosphorylation (GO:0006975) | 3.28106941 |
| 111 | lysine metabolic process (GO:0006553) | 3.24883338 |
| 112 | lysine catabolic process (GO:0006554) | 3.24883338 |
| 113 | glycine metabolic process (GO:0006544) | 3.24348790 |
| 114 | nucleoside transmembrane transport (GO:1901642) | 3.23888946 |
| 115 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.22284608 |
| 116 | primary alcohol catabolic process (GO:0034310) | 3.20942576 |
| 117 | amyloid precursor protein catabolic process (GO:0042987) | 3.20025354 |
| 118 | tyrosine metabolic process (GO:0006570) | 3.17353862 |
| 119 | phospholipid homeostasis (GO:0055091) | 3.15647809 |
| 120 | short-chain fatty acid metabolic process (GO:0046459) | 3.15152083 |
| 121 | phosphatidylethanolamine metabolic process (GO:0046337) | 3.14428013 |
| 122 | adenine nucleotide transport (GO:0051503) | 3.13966033 |
| 123 | fibrinolysis (GO:0042730) | 3.13556713 |
| 124 | alpha-amino acid catabolic process (GO:1901606) | 3.13538663 |
| 125 | coenzyme catabolic process (GO:0009109) | 3.13316738 |
| 126 | serine family amino acid metabolic process (GO:0009069) | 3.10901366 |
| 127 | negative regulation of lipase activity (GO:0060192) | 3.09810995 |
| 128 | response to mercury ion (GO:0046689) | 3.09538824 |
| 129 | bile acid and bile salt transport (GO:0015721) | 3.08763077 |
| 130 | regulation of cholesterol metabolic process (GO:0090181) | 3.07782117 |
| 131 | cofactor catabolic process (GO:0051187) | 3.05699538 |
| 132 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.03657428 |
| 133 | heme transport (GO:0015886) | 3.03435179 |
| 134 | postsynaptic membrane organization (GO:0001941) | 3.02793981 |
| 135 | semaphorin-plexin signaling pathway (GO:0071526) | 3.02626560 |
| 136 | regulation of ARF GTPase activity (GO:0032312) | 3.01229750 |
| 137 | drug catabolic process (GO:0042737) | 3.00847955 |
| 138 | cellular amino acid catabolic process (GO:0009063) | 3.00674263 |
| 139 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.00149443 |
| 140 | glutamate metabolic process (GO:0006536) | 3.00121587 |
| 141 | lipoprotein metabolic process (GO:0042157) | 2.99838508 |
| 142 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.99547564 |
| 143 | folic acid metabolic process (GO:0046655) | 2.98760007 |
| 144 | aldehyde catabolic process (GO:0046185) | 2.97796368 |
| 145 | very long-chain fatty acid metabolic process (GO:0000038) | 2.97408092 |
| 146 | acetyl-CoA metabolic process (GO:0006084) | 2.97366915 |
| 147 | imidazole-containing compound metabolic process (GO:0052803) | 2.97002180 |
| 148 | biotin metabolic process (GO:0006768) | 2.96683465 |
| 149 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 2.96570529 |
| 150 | cofactor transport (GO:0051181) | 2.96529640 |
| 151 | intestinal absorption (GO:0050892) | 2.96195034 |
| 152 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 2.95791591 |
| 153 | fatty acid beta-oxidation (GO:0006635) | 2.95237292 |
| 154 | regulation of cholesterol storage (GO:0010885) | 2.94561994 |
| 155 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.94253291 |
| 156 | plasma lipoprotein particle organization (GO:0071827) | 2.93708187 |
| 157 | regulation of triglyceride metabolic process (GO:0090207) | 2.93576795 |
| 158 | heart valve formation (GO:0003188) | 2.93262765 |
| 159 | DNA alkylation (GO:0006305) | 2.92764679 |
| 160 | DNA methylation (GO:0006306) | 2.92764679 |
| 161 | fatty acid catabolic process (GO:0009062) | 2.91354091 |
| 162 | cellular ketone body metabolic process (GO:0046950) | 2.91256157 |
| 163 | serine family amino acid biosynthetic process (GO:0009070) | 2.90989689 |
| 164 | fatty acid oxidation (GO:0019395) | 2.90330836 |
| 165 | protein-lipid complex subunit organization (GO:0071825) | 2.89212680 |
| 166 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.88801469 |
| 167 | purine ribonucleotide transport (GO:0015868) | 2.88018829 |
| 168 | drug transmembrane transport (GO:0006855) | 2.86405405 |
| 169 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.83437374 |
| 170 | lens fiber cell differentiation (GO:0070306) | 2.82240061 |
| 171 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.80434370 |
| 172 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.78366145 |
| 173 | detection of light stimulus involved in visual perception (GO:0050908) | 2.78366145 |
| 174 | transepithelial transport (GO:0070633) | 2.77390700 |
| 175 | purine nucleotide transport (GO:0015865) | 2.76667924 |
| 176 | regulation of interleukin-5 production (GO:0032674) | 2.75447006 |
| 177 | positive regulation of catecholamine secretion (GO:0033605) | 2.75428880 |
| 178 | regulation of developmental pigmentation (GO:0048070) | 2.73933548 |
| 179 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.73886812 |
| 180 | negative regulation of stem cell proliferation (GO:2000647) | 2.73439232 |
| 181 | UV protection (GO:0009650) | 2.67249673 |
| 182 | peristalsis (GO:0030432) | 2.64336327 |
| 183 | mitotic cell cycle arrest (GO:0071850) | 2.61651574 |
| 184 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.60480265 |
| 185 | germinal center formation (GO:0002467) | 2.58909486 |
| 186 | positive regulation of histone deacetylation (GO:0031065) | 2.58855557 |
| 187 | serotonin receptor signaling pathway (GO:0007210) | 2.57855493 |
| 188 | positive regulation of fatty acid oxidation (GO:0046321) | 2.57034630 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.29358578 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.29588163 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.91007538 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.14037603 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.78479346 |
| 6 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.68673780 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.52536985 |
| 8 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.27195638 |
| 9 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 3.20042047 |
| 10 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.92107517 |
| 11 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.73090017 |
| 12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.43527877 |
| 13 | CTCF_27219007_Chip-Seq_Bcells_Human | 2.39153429 |
| 14 | E2F1_20622854_ChIP-Seq_HELA_Human | 2.38567348 |
| 15 | SMC4_20622854_ChIP-Seq_HELA_Human | 2.27329803 |
| 16 | * PHF8_20622854_ChIP-Seq_HELA_Human | 2.11083360 |
| 17 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 2.08592143 |
| 18 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.05032118 |
| 19 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.97848340 |
| 20 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.95311131 |
| 21 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.94057541 |
| 22 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.89555745 |
| 23 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.87070267 |
| 24 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.86985527 |
| 25 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.86376636 |
| 26 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.86141245 |
| 27 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.83938379 |
| 28 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.82021236 |
| 29 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.80001140 |
| 30 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.73316622 |
| 31 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.73258411 |
| 32 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.72479106 |
| 33 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.71830384 |
| 34 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.67988653 |
| 35 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.66244723 |
| 36 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.65804178 |
| 37 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.64952270 |
| 38 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.63504421 |
| 39 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.62481163 |
| 40 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.61960517 |
| 41 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.60271235 |
| 42 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.58836803 |
| 43 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.54809957 |
| 44 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.54774201 |
| 45 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.52865796 |
| 46 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.52855175 |
| 47 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.52800050 |
| 48 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.52725682 |
| 49 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.52506975 |
| 50 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.51314179 |
| 51 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.49874352 |
| 52 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.48884480 |
| 53 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.48697526 |
| 54 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.47378693 |
| 55 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.47141671 |
| 56 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.46695551 |
| 57 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.45828919 |
| 58 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.44106965 |
| 59 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.42850979 |
| 60 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.42332765 |
| 61 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.42280847 |
| 62 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.40340952 |
| 63 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.39351211 |
| 64 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.38936689 |
| 65 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.38170351 |
| 66 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.37122589 |
| 67 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.37045032 |
| 68 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.35357512 |
| 69 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.35171296 |
| 70 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.35022675 |
| 71 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.33931684 |
| 72 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.33502894 |
| 73 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.33065248 |
| 74 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.32139623 |
| 75 | FLI1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.31316663 |
| 76 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.31206743 |
| 77 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.29512993 |
| 78 | KDM2B_26808549_Chip-Seq_K562_Human | 1.28863785 |
| 79 | ERA_21632823_ChIP-Seq_H3396_Human | 1.28630861 |
| 80 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.27406903 |
| 81 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.27186743 |
| 82 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.26914264 |
| 83 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.26739004 |
| 84 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.26571778 |
| 85 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.26463451 |
| 86 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.24690069 |
| 87 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.24436219 |
| 88 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.24055890 |
| 89 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.22995326 |
| 90 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.22290867 |
| 91 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.21907378 |
| 92 | MAF_26560356_Chip-Seq_TH1_Human | 1.21502534 |
| 93 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.20598301 |
| 94 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.19921922 |
| 95 | ATF3_27146783_Chip-Seq_COLON_Human | 1.19512220 |
| 96 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.17211428 |
| 97 | P300_27268052_Chip-Seq_Bcells_Human | 1.16315629 |
| 98 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.15926658 |
| 99 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.14630662 |
| 100 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.13754297 |
| 101 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.13599928 |
| 102 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13142038 |
| 103 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.12852188 |
| 104 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.12588733 |
| 105 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.11742912 |
| 106 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 1.11587691 |
| 107 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.11316777 |
| 108 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.10826985 |
| 109 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.10483251 |
| 110 | GATA1_22025678_ChIP-Seq_K562_Human | 1.10373525 |
| 111 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.10303209 |
| 112 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.08738516 |
| 113 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.08564424 |
| 114 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.08269209 |
| 115 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.08136731 |
| 116 | KLF4_19829295_ChIP-Seq_ESCs_Human | 1.08020646 |
| 117 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07968249 |
| 118 | MYC_22102868_ChIP-Seq_BL_Human | 1.07789344 |
| 119 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.07393118 |
| 120 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 1.07257692 |
| 121 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.06676881 |
| 122 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.06611410 |
| 123 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.06468829 |
| 124 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.05920173 |
| 125 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05711270 |
| 126 | GATA1_19941826_ChIP-Seq_K562_Human | 1.05550439 |
| 127 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.03999089 |
| 128 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03265612 |
| 129 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.00738155 |
| 130 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.99793817 |
| 131 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.99659709 |
| 132 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.99420775 |
| 133 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.98714788 |
| 134 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.98426658 |
| 135 | P68_20966046_ChIP-Seq_HELA_Human | 0.97750998 |
| 136 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.95995648 |
| 137 | MAF_26560356_Chip-Seq_TH2_Human | 0.95478294 |
| 138 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.93296864 |
| 139 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.92727796 |
| 140 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.92353933 |
| 141 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.92067164 |
| 142 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.91411421 |
| 143 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.90311819 |
| 144 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.88958355 |
| 145 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.88766159 |
| 146 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.87676023 |
| 147 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.87486913 |
| 148 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.87136710 |
| 149 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.85854153 |
| 150 | SA1_27219007_Chip-Seq_Bcells_Human | 0.85596147 |
| 151 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.85205478 |
| 152 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.84909821 |
| 153 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.84857477 |
| 154 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.84478569 |
| 155 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.84427911 |
| 156 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.84207358 |
| 157 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.83554974 |
| 158 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.83082939 |
| 159 | * SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.83064152 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005171_absent_coat_pigmentation | 8.57302413 |
| 2 | MP0003136_yellow_coat_color | 7.88687597 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 5.79444077 |
| 4 | MP0002837_dystrophic_cardiac_calcinosis | 5.56140532 |
| 5 | MP0005360_urolithiasis | 5.55909100 |
| 6 | MP0002653_abnormal_ependyma_morphology | 4.35541160 |
| 7 | MP0009840_abnormal_foam_cell | 4.27525290 |
| 8 | MP0005365_abnormal_bile_salt | 4.27208034 |
| 9 | MP0005085_abnormal_gallbladder_physiolo | 4.17370412 |
| 10 | MP0008875_abnormal_xenobiotic_pharmacok | 3.53666406 |
| 11 | MP0003045_fibrosis | 3.27600481 |
| 12 | MP0003191_abnormal_cellular_cholesterol | 3.14097155 |
| 13 | MP0001986_abnormal_taste_sensitivity | 3.09043039 |
| 14 | MP0005423_abnormal_somatic_nervous | 3.02139351 |
| 15 | MP0005174_abnormal_tail_pigmentation | 2.98265899 |
| 16 | MP0003879_abnormal_hair_cell | 2.94534003 |
| 17 | MP0003806_abnormal_nucleotide_metabolis | 2.90546395 |
| 18 | MP0005083_abnormal_biliary_tract | 2.80028307 |
| 19 | MP0010329_abnormal_lipoprotein_level | 2.70408791 |
| 20 | MP0001666_abnormal_nutrient_absorption | 2.59350701 |
| 21 | MP0003252_abnormal_bile_duct | 2.56429200 |
| 22 | MP0003890_abnormal_embryonic-extraembry | 2.45043594 |
| 23 | MP0003195_calcinosis | 2.38581949 |
| 24 | MP0005058_abnormal_lysosome_morphology | 2.35165858 |
| 25 | MP0002796_impaired_skin_barrier | 2.13871184 |
| 26 | MP0005332_abnormal_amino_acid | 2.09375903 |
| 27 | MP0003705_abnormal_hypodermis_morpholog | 1.98627099 |
| 28 | MP0000609_abnormal_liver_physiology | 1.98127268 |
| 29 | MP0001968_abnormal_touch/_nociception | 1.87675995 |
| 30 | MP0003303_peritoneal_inflammation | 1.85996217 |
| 31 | MP0002118_abnormal_lipid_homeostasis | 1.85450386 |
| 32 | MP0005451_abnormal_body_composition | 1.81663481 |
| 33 | MP0003646_muscle_fatigue | 1.77137511 |
| 34 | MP0004147_increased_porphyrin_level | 1.74772800 |
| 35 | MP0000604_amyloidosis | 1.67218849 |
| 36 | MP0002735_abnormal_chemical_nociception | 1.67105766 |
| 37 | MP0003300_gastrointestinal_ulcer | 1.65875115 |
| 38 | MP0004185_abnormal_adipocyte_glucose | 1.62275480 |
| 39 | MP0003436_decreased_susceptibility_to | 1.61035816 |
| 40 | MP0004019_abnormal_vitamin_homeostasis | 1.59484260 |
| 41 | MP0004947_skin_inflammation | 1.57033793 |
| 42 | MP0005076_abnormal_cell_differentiation | 1.56320557 |
| 43 | MP0002254_reproductive_system_inflammat | 1.53355551 |
| 44 | MP0009643_abnormal_urine_homeostasis | 1.50800503 |
| 45 | MP0002138_abnormal_hepatobiliary_system | 1.50750446 |
| 46 | MP0006082_CNS_inflammation | 1.49816202 |
| 47 | MP0005319_abnormal_enzyme/_coenzyme | 1.47632596 |
| 48 | MP0003656_abnormal_erythrocyte_physiolo | 1.38484166 |
| 49 | MP0001661_extended_life_span | 1.32903488 |
| 50 | MP0003453_abnormal_keratinocyte_physiol | 1.31503109 |
| 51 | MP0003878_abnormal_ear_physiology | 1.26370953 |
| 52 | MP0005377_hearing/vestibular/ear_phenot | 1.26370953 |
| 53 | MP0004859_abnormal_synaptic_plasticity | 1.24745541 |
| 54 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.24049536 |
| 55 | MP0005330_cardiomyopathy | 1.23368589 |
| 56 | MP0002736_abnormal_nociception_after | 1.21873409 |
| 57 | MP0008469_abnormal_protein_level | 1.21469753 |
| 58 | MP0005501_abnormal_skin_physiology | 1.20316582 |
| 59 | MP0001502_abnormal_circadian_rhythm | 1.19585259 |
| 60 | MP0002160_abnormal_reproductive_system | 1.17954991 |
| 61 | MP0003868_abnormal_feces_composition | 1.15207918 |
| 62 | MP0003329_amyloid_beta_deposits | 1.14912728 |
| 63 | MP0010234_abnormal_vibrissa_follicle | 1.13090602 |
| 64 | MP0005464_abnormal_platelet_physiology | 1.12985565 |
| 65 | MP0001188_hyperpigmentation | 1.11142618 |
| 66 | MP0002168_other_aberrant_phenotype | 1.09895752 |
| 67 | MP0005410_abnormal_fertilization | 1.08960837 |
| 68 | MP0003137_abnormal_impulse_conducting | 1.08484049 |
| 69 | MP0000015_abnormal_ear_pigmentation | 1.08428410 |
| 70 | MP0005025_abnormal_response_to | 1.04675633 |
| 71 | MP0000598_abnormal_liver_morphology | 1.04568115 |
| 72 | MP0002075_abnormal_coat/hair_pigmentati | 1.03998517 |
| 73 | MP0005387_immune_system_phenotype | 1.03638744 |
| 74 | MP0001790_abnormal_immune_system | 1.03638744 |
| 75 | MP0000685_abnormal_immune_system | 1.03228502 |
| 76 | MP0001216_abnormal_epidermal_layer | 1.02901138 |
| 77 | MP0005666_abnormal_adipose_tissue | 1.02740673 |
| 78 | MP0000579_abnormal_nail_morphology | 1.00168935 |
| 79 | MP0003635_abnormal_synaptic_transmissio | 0.99740702 |
| 80 | MP0001970_abnormal_pain_threshold | 0.98469908 |
| 81 | MP0002419_abnormal_innate_immunity | 0.97216821 |
| 82 | MP0003724_increased_susceptibility_to | 0.96615080 |
| 83 | MP0005409_darkened_coat_color | 0.96205154 |
| 84 | MP0005075_abnormal_melanosome_morpholog | 0.96012865 |
| 85 | MP0002060_abnormal_skin_morphology | 0.96001091 |
| 86 | MP0004381_abnormal_hair_follicle | 0.92877176 |
| 87 | MP0005636_abnormal_mineral_homeostasis | 0.92621574 |
| 88 | MP0009763_increased_sensitivity_to | 0.91725584 |
| 89 | MP0001764_abnormal_homeostasis | 0.90802814 |
| 90 | MP0001845_abnormal_inflammatory_respons | 0.88164320 |
| 91 | MP0001664_abnormal_digestion | 0.87633362 |
| 92 | MP0003075_altered_response_to | 0.86186475 |
| 93 | MP0003690_abnormal_glial_cell | 0.86099345 |
| 94 | MP0000749_muscle_degeneration | 0.85561557 |
| 95 | MP0002064_seizures | 0.85262067 |
| 96 | MP0003186_abnormal_redox_activity | 0.84242174 |
| 97 | MP0001533_abnormal_skeleton_physiology | 0.84031757 |
| 98 | MP0001851_eye_inflammation | 0.83443883 |
| 99 | MP0002098_abnormal_vibrissa_morphology | 0.83312044 |
| 100 | MP0002938_white_spotting | 0.83280140 |
| 101 | MP0009642_abnormal_blood_homeostasis | 0.82940817 |
| 102 | MP0009764_decreased_sensitivity_to | 0.81805743 |
| 103 | MP0001486_abnormal_startle_reflex | 0.81701058 |
| 104 | MP0009785_altered_susceptibility_to | 0.78861528 |
| 105 | MP0003172_abnormal_lysosome_physiology | 0.78496323 |
| 106 | MP0004043_abnormal_pH_regulation | 0.77689464 |
| 107 | MP0000377_abnormal_hair_follicle | 0.76467498 |
| 108 | MP0004130_abnormal_muscle_cell | 0.76210219 |
| 109 | MP0005000_abnormal_immune_tolerance | 0.75276975 |
| 110 | MP0000467_abnormal_esophagus_morphology | 0.74840331 |
| 111 | MP0002971_abnormal_brown_adipose | 0.74559401 |
| 112 | MP0003011_delayed_dark_adaptation | 0.74447074 |
| 113 | MP0008569_lethality_at_weaning | 0.74114244 |
| 114 | MP0002136_abnormal_kidney_physiology | 0.73501936 |
| 115 | MP0010155_abnormal_intestine_physiology | 0.73331813 |
| 116 | MP0000538_abnormal_urinary_bladder | 0.72604984 |
| 117 | MP0002078_abnormal_glucose_homeostasis | 0.72370293 |
| 118 | MP0003111_abnormal_nucleus_morphology | 0.72293011 |
| 119 | MP0001243_abnormal_dermal_layer | 0.72256661 |
| 120 | MP0008770_decreased_survivor_rate | 0.71898792 |
| 121 | MP0002272_abnormal_nervous_system | 0.71524175 |
| 122 | MP0009931_abnormal_skin_appearance | 0.71375755 |
| 123 | MP0005670_abnormal_white_adipose | 0.71007867 |
| 124 | MP0000751_myopathy | 0.70828786 |
| 125 | MP0003566_abnormal_cell_adhesion | 0.70705465 |
| 126 | MP0009745_abnormal_behavioral_response | 0.70698461 |
| 127 | MP0009278_abnormal_bone_marrow | 0.70612969 |
| 128 | MP0000470_abnormal_stomach_morphology | 0.70489008 |
| 129 | MP0005375_adipose_tissue_phenotype | 0.70134933 |
| 130 | MP0004510_myositis | 0.69529212 |
| 131 | MP0005551_abnormal_eye_electrophysiolog | 0.68664601 |
| 132 | MP0001765_abnormal_ion_homeostasis | 0.68420391 |
| 133 | MP0001800_abnormal_humoral_immune | 0.68382280 |
| 134 | MP0002063_abnormal_learning/memory/cond | 0.68249112 |
| 135 | MP0002723_abnormal_immune_serum | 0.68096153 |
| 136 | MP0001756_abnormal_urination | 0.67791439 |
| 137 | MP0005023_abnormal_wound_healing | 0.67471211 |
| 138 | MP0002572_abnormal_emotion/affect_behav | 0.66134001 |
| 139 | MP0005220_abnormal_exocrine_pancreas | 0.65081017 |
| 140 | MP0001849_ear_inflammation | 0.65037004 |
| 141 | MP0008961_abnormal_basal_metabolism | 0.63963890 |
| 142 | MP0005334_abnormal_fat_pad | 0.63361411 |
| 143 | MP0004233_abnormal_muscle_weight | 0.60904730 |
| 144 | MP0005166_decreased_susceptibility_to | 0.60822514 |
| 145 | MP0005395_other_phenotype | 0.60558714 |
| 146 | MP0002249_abnormal_larynx_morphology | 0.60327274 |
| 147 | MP0010771_integument_phenotype | 0.60309081 |
| 148 | MP0001835_abnormal_antigen_presentation | 0.59394781 |
| 149 | MP0004264_abnormal_extraembryonic_tissu | 0.59373565 |
| 150 | MP0002733_abnormal_thermal_nociception | 0.59165419 |
| 151 | MP0005257_abnormal_intraocular_pressure | 0.58803015 |
| 152 | MP0002638_abnormal_pupillary_reflex | 0.58696721 |
| 153 | MP0003638_abnormal_response/metabolism_ | 0.58336431 |
| 154 | MP0001853_heart_inflammation | 0.57594156 |
| 155 | MP0003183_abnormal_peptide_metabolism | 0.57051025 |
| 156 | MP0004858_abnormal_nervous_system | 0.57025634 |
| 157 | MP0008872_abnormal_physiological_respon | 0.56274955 |
| 158 | MP0001186_pigmentation_phenotype | 0.53174340 |
| 159 | MP0001348_abnormal_lacrimal_gland | 0.51224862 |
| 160 | MP0000534_abnormal_ureter_morphology | 0.50382874 |
| 161 | MP0001324_abnormal_eye_pigmentation | 0.47718704 |
| 162 | MP0000003_abnormal_adipose_tissue | 0.47567498 |
| 163 | MP0002095_abnormal_skin_pigmentation | 0.46013178 |
| 164 | MP0000026_abnormal_inner_ear | 0.44518303 |
| 165 | MP0000678_abnormal_parathyroid_gland | 0.43473909 |
| 166 | MP0003632_abnormal_nervous_system | 0.42297966 |
| 167 | MP0000367_abnormal_coat/_hair | 0.42232928 |
| 168 | MP0001501_abnormal_sleep_pattern | 0.40750583 |
| 169 | MP0001963_abnormal_hearing_physiology | 0.39998194 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Amelogenesis imperfecta (HP:0000705) | 6.50358260 |
| 2 | Ulnar bowing (HP:0003031) | 6.04589668 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.72657374 |
| 4 | Xanthomatosis (HP:0000991) | 5.30826414 |
| 5 | Focal motor seizures (HP:0011153) | 5.17226565 |
| 6 | Intrahepatic cholestasis (HP:0001406) | 5.07125291 |
| 7 | Testicular atrophy (HP:0000029) | 5.01162187 |
| 8 | Deep venous thrombosis (HP:0002625) | 4.91323502 |
| 9 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.89537110 |
| 10 | Rib fusion (HP:0000902) | 4.53008749 |
| 11 | Annular pancreas (HP:0001734) | 4.20765514 |
| 12 | Hyperlipoproteinemia (HP:0010980) | 4.11839330 |
| 13 | Hypobetalipoproteinemia (HP:0003563) | 4.07218786 |
| 14 | Complement deficiency (HP:0004431) | 4.04223185 |
| 15 | Prolonged partial thromboplastin time (HP:0003645) | 3.98768495 |
| 16 | Rectovaginal fistula (HP:0000143) | 3.95426184 |
| 17 | Rectal fistula (HP:0100590) | 3.95426184 |
| 18 | Vaginal fistula (HP:0004320) | 3.93320192 |
| 19 | Rectal prolapse (HP:0002035) | 3.92048347 |
| 20 | Intestinal fistula (HP:0100819) | 3.88543797 |
| 21 | Mesangial abnormality (HP:0001966) | 3.85810999 |
| 22 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.78169368 |
| 23 | Congenital stationary night blindness (HP:0007642) | 3.70283134 |
| 24 | Systemic lupus erythematosus (HP:0002725) | 3.65921798 |
| 25 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 3.53400714 |
| 26 | Attenuation of retinal blood vessels (HP:0007843) | 3.46885752 |
| 27 | Hyperammonemia (HP:0001987) | 3.44726463 |
| 28 | Parakeratosis (HP:0001036) | 3.43074680 |
| 29 | Myocardial infarction (HP:0001658) | 3.41210754 |
| 30 | Vacuolated lymphocytes (HP:0001922) | 3.38979986 |
| 31 | Abnormality of complement system (HP:0005339) | 3.37270204 |
| 32 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.35384349 |
| 33 | Abnormal albumin level (HP:0012116) | 3.34175589 |
| 34 | Hypoalbuminemia (HP:0003073) | 3.34175589 |
| 35 | Pendular nystagmus (HP:0012043) | 3.30051093 |
| 36 | Akinesia (HP:0002304) | 3.26089591 |
| 37 | Joint hemorrhage (HP:0005261) | 3.25910772 |
| 38 | Axonal loss (HP:0003447) | 3.23695689 |
| 39 | Ketosis (HP:0001946) | 3.22665793 |
| 40 | Facial diplegia (HP:0001349) | 3.21353912 |
| 41 | Thin bony cortex (HP:0002753) | 3.20493976 |
| 42 | Hypolipoproteinemia (HP:0010981) | 3.19256874 |
| 43 | Bowed forearm bones (HP:0003956) | 3.19226856 |
| 44 | Bowing of the arm (HP:0006488) | 3.19226856 |
| 45 | Abnormality of the common coagulation pathway (HP:0010990) | 3.14796395 |
| 46 | Hypercholesterolemia (HP:0003124) | 3.13102253 |
| 47 | Fat malabsorption (HP:0002630) | 3.11317983 |
| 48 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.04718147 |
| 49 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.04348298 |
| 50 | Epidermoid cyst (HP:0200040) | 3.04184505 |
| 51 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.04054374 |
| 52 | Poikiloderma (HP:0001029) | 2.97503067 |
| 53 | Atrioventricular block (HP:0001678) | 2.94481522 |
| 54 | Hyperglycinemia (HP:0002154) | 2.93980158 |
| 55 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.91923466 |
| 56 | Hypoalphalipoproteinemia (HP:0003233) | 2.91461497 |
| 57 | Malnutrition (HP:0004395) | 2.86975382 |
| 58 | Coronal craniosynostosis (HP:0004440) | 2.84078838 |
| 59 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.83496471 |
| 60 | Abnormality of glycine metabolism (HP:0010895) | 2.83496471 |
| 61 | Dyschromatopsia (HP:0007641) | 2.82953584 |
| 62 | Glomerulonephritis (HP:0000099) | 2.81907507 |
| 63 | Difficulty walking (HP:0002355) | 2.81461581 |
| 64 | Late onset (HP:0003584) | 2.79450922 |
| 65 | Conjugated hyperbilirubinemia (HP:0002908) | 2.79186322 |
| 66 | Hyperglycinuria (HP:0003108) | 2.78326661 |
| 67 | Dysostosis multiplex (HP:0000943) | 2.77517097 |
| 68 | Hypoglycemic coma (HP:0001325) | 2.68317640 |
| 69 | Aplastic anemia (HP:0001915) | 2.67632604 |
| 70 | Myopathic facies (HP:0002058) | 2.60824003 |
| 71 | Amyloidosis (HP:0011034) | 2.59126578 |
| 72 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.58515910 |
| 73 | Abnormality of the intrinsic pathway (HP:0010989) | 2.57958251 |
| 74 | Patellar aplasia (HP:0006443) | 2.54232498 |
| 75 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.52904253 |
| 76 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.48144530 |
| 77 | Skin nodule (HP:0200036) | 2.46675109 |
| 78 | Abnormality of the Achilles tendon (HP:0005109) | 2.45978374 |
| 79 | Ketoacidosis (HP:0001993) | 2.42794862 |
| 80 | Increased serum ferritin (HP:0003281) | 2.42425883 |
| 81 | Mucopolysacchariduria (HP:0008155) | 2.41168314 |
| 82 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.41168314 |
| 83 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.40714871 |
| 84 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.39174502 |
| 85 | Delayed epiphyseal ossification (HP:0002663) | 2.38143265 |
| 86 | Abnormality of iron homeostasis (HP:0011031) | 2.37235143 |
| 87 | Focal seizures (HP:0007359) | 2.37095082 |
| 88 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.36967325 |
| 89 | Abnormality of methionine metabolism (HP:0010901) | 2.35191255 |
| 90 | Ankle clonus (HP:0011448) | 2.33587311 |
| 91 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.33340456 |
| 92 | Facial hemangioma (HP:0000329) | 2.33300383 |
| 93 | Hyperbilirubinemia (HP:0002904) | 2.31156576 |
| 94 | Abnormality of purine metabolism (HP:0004352) | 2.30782265 |
| 95 | Polycythemia (HP:0001901) | 2.28615377 |
| 96 | Birth length less than 3rd percentile (HP:0003561) | 2.28346958 |
| 97 | Chorioretinal atrophy (HP:0000533) | 2.27966967 |
| 98 | Decreased circulating renin level (HP:0003351) | 2.27776296 |
| 99 | Anteriorly placed anus (HP:0001545) | 2.26229742 |
| 100 | Choanal stenosis (HP:0000452) | 2.26029111 |
| 101 | Steatorrhea (HP:0002570) | 2.25113321 |
| 102 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.22717126 |
| 103 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.22717126 |
| 104 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.22717126 |
| 105 | Vertebral arch anomaly (HP:0008438) | 2.21877726 |
| 106 | Eczematoid dermatitis (HP:0000976) | 2.21526972 |
| 107 | Gingival bleeding (HP:0000225) | 2.21013995 |
| 108 | Abnormality of the fingertips (HP:0001211) | 2.18404519 |
| 109 | Widely patent fontanelles and sutures (HP:0004492) | 2.18297690 |
| 110 | Dialeptic seizures (HP:0011146) | 2.18218286 |
| 111 | Abnormality of the hepatic vasculature (HP:0006707) | 2.18121777 |
| 112 | Acanthocytosis (HP:0001927) | 2.17397134 |
| 113 | Abnormality of nucleobase metabolism (HP:0010932) | 2.16931949 |
| 114 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.15941945 |
| 115 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.14007374 |
| 116 | Upper limb amyotrophy (HP:0009129) | 2.13742139 |
| 117 | Distal upper limb amyotrophy (HP:0007149) | 2.13742139 |
| 118 | Neurofibrillary tangles (HP:0002185) | 2.10296677 |
| 119 | Peritonitis (HP:0002586) | 2.09842309 |
| 120 | Nephritis (HP:0000123) | 2.08860721 |
| 121 | Mitral stenosis (HP:0001718) | 2.08341741 |
| 122 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.07188913 |
| 123 | Dicarboxylic aciduria (HP:0003215) | 2.07188913 |
| 124 | Menorrhagia (HP:0000132) | 2.06909173 |
| 125 | Macular degeneration (HP:0000608) | 2.06186273 |
| 126 | Brushfield spots (HP:0001088) | 2.05855861 |
| 127 | Abnormality of the costochondral junction (HP:0000919) | 2.05628275 |
| 128 | Severe visual impairment (HP:0001141) | 2.05531756 |
| 129 | Metabolic acidosis (HP:0001942) | 2.04668696 |
| 130 | Global brain atrophy (HP:0002283) | 2.03765739 |
| 131 | Achilles tendon contracture (HP:0001771) | 2.03595829 |
| 132 | Aplasia of the musculature (HP:0100854) | 2.03223794 |
| 133 | Increased cerebral lipofuscin (HP:0011813) | 2.02773771 |
| 134 | Hypoplasia of the pons (HP:0012110) | 2.02702545 |
| 135 | Facial shape deformation (HP:0011334) | 2.02382239 |
| 136 | Potter facies (HP:0002009) | 2.02382239 |
| 137 | Esophageal varix (HP:0002040) | 2.01956272 |
| 138 | Hypophosphatemic rickets (HP:0004912) | 2.00654070 |
| 139 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.00285380 |
| 140 | Type I transferrin isoform profile (HP:0003642) | 1.99985684 |
| 141 | Hydroxyprolinuria (HP:0003080) | 1.99134237 |
| 142 | Abnormality of proline metabolism (HP:0010907) | 1.99134237 |
| 143 | Abnormal gallbladder morphology (HP:0012437) | 1.98248902 |
| 144 | Neonatal respiratory distress (HP:0002643) | 1.98016849 |
| 145 | Delayed CNS myelination (HP:0002188) | 1.96148419 |
| 146 | Irritability (HP:0000737) | 1.96085502 |
| 147 | Hand muscle atrophy (HP:0009130) | 1.95700967 |
| 148 | Right ventricular cardiomyopathy (HP:0011663) | 1.94444963 |
| 149 | Gout (HP:0001997) | 1.93924884 |
| 150 | Abnormality of macrophages (HP:0004311) | 1.92474303 |
| 151 | Stridor (HP:0010307) | 1.92456885 |
| 152 | External ophthalmoplegia (HP:0000544) | 1.91256937 |
| 153 | Heart block (HP:0012722) | 1.90932928 |
| 154 | Vascular calcification (HP:0004934) | 1.90297574 |
| 155 | Pancreatitis (HP:0001733) | 1.89446566 |
| 156 | Cholelithiasis (HP:0001081) | 1.89413832 |
| 157 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.89231318 |
| 158 | Sensorimotor neuropathy (HP:0007141) | 1.87217456 |
| 159 | Elevated alkaline phosphatase (HP:0003155) | 1.87035330 |
| 160 | Protuberant abdomen (HP:0001538) | 1.86866304 |
| 161 | Opisthotonus (HP:0002179) | 1.86733550 |
| 162 | Cerebral inclusion bodies (HP:0100314) | 1.86327128 |
| 163 | Carpal synostosis (HP:0009702) | 1.85487727 |
| 164 | Abnormal atrioventricular conduction (HP:0005150) | 1.85448846 |
| 165 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.84875743 |
| 166 | Hemorrhage of the eye (HP:0011885) | 1.84829885 |
| 167 | Myotonia (HP:0002486) | 1.83734923 |
| 168 | Scapular winging (HP:0003691) | 1.83703557 |
| 169 | Loss of speech (HP:0002371) | 1.83415566 |
| 170 | Poikilocytosis (HP:0004447) | 1.83252663 |
| 171 | Popliteal pterygium (HP:0009756) | 1.82935682 |
| 172 | Urticaria (HP:0001025) | 1.81512805 |
| 173 | Spontaneous hematomas (HP:0007420) | 1.80801596 |
| 174 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.79849480 |
| 175 | Squamous cell carcinoma (HP:0002860) | 1.79594756 |
| 176 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.78747827 |
| 177 | Turricephaly (HP:0000262) | 1.78222982 |
| 178 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.77434345 |
| 179 | Neonatal onset (HP:0003623) | 1.77083173 |
| 180 | Ileus (HP:0002595) | 1.77028387 |
| 181 | Colitis (HP:0002583) | 1.76765379 |
| 182 | Bronchomalacia (HP:0002780) | 1.76212386 |
| 183 | Short chin (HP:0000331) | 1.75389490 |
| 184 | Narrow nasal bridge (HP:0000446) | 1.75387081 |
| 185 | Fetal akinesia sequence (HP:0001989) | 1.75277188 |
| 186 | Pustule (HP:0200039) | 1.74723469 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | LATS1 | 8.01863568 |
| 2 | LATS2 | 5.58267382 |
| 3 | STK38L | 5.26437724 |
| 4 | ERN1 | 5.14059010 |
| 5 | PRKD3 | 4.14326038 |
| 6 | TRIB3 | 3.42679055 |
| 7 | ZAK | 2.95698371 |
| 8 | MAP3K10 | 2.85128063 |
| 9 | BCKDK | 2.78735073 |
| 10 | EPHB1 | 2.61310436 |
| 11 | STK38 | 2.58601659 |
| 12 | FGFR4 | 2.57755795 |
| 13 | ACVR1B | 2.57470964 |
| 14 | TAOK3 | 2.53294532 |
| 15 | TBK1 | 2.48838922 |
| 16 | BLK | 2.14249222 |
| 17 | SIK1 | 2.09936317 |
| 18 | MAP4K1 | 1.99205873 |
| 19 | MAP2K2 | 1.97914170 |
| 20 | TYK2 | 1.96030911 |
| 21 | MAPK15 | 1.88920256 |
| 22 | PKN2 | 1.86421458 |
| 23 | ICK | 1.78755121 |
| 24 | MST1R | 1.69363642 |
| 25 | PTK6 | 1.64378805 |
| 26 | MELK | 1.60684786 |
| 27 | MAP3K11 | 1.58391464 |
| 28 | IKBKE | 1.52833563 |
| 29 | FLT3 | 1.46354703 |
| 30 | GRK6 | 1.45118359 |
| 31 | DAPK2 | 1.43549106 |
| 32 | TAOK1 | 1.40131319 |
| 33 | KIT | 1.39712244 |
| 34 | IRAK3 | 1.34933833 |
| 35 | NLK | 1.31513594 |
| 36 | PIK3CG | 1.29433767 |
| 37 | CSK | 1.25231091 |
| 38 | LMTK2 | 1.24379280 |
| 39 | NEK2 | 1.17004587 |
| 40 | MAPK11 | 1.15802564 |
| 41 | STK10 | 1.15737844 |
| 42 | TNK2 | 1.11818517 |
| 43 | EEF2K | 1.11559472 |
| 44 | ZAP70 | 1.09666272 |
| 45 | PIM2 | 1.09513251 |
| 46 | SMG1 | 1.08165635 |
| 47 | WNK4 | 1.06134598 |
| 48 | MAP3K3 | 1.05917130 |
| 49 | STK3 | 1.05833855 |
| 50 | SIK2 | 1.04547822 |
| 51 | DYRK1B | 1.00974380 |
| 52 | LRRK2 | 0.97143744 |
| 53 | RIPK1 | 0.96257468 |
| 54 | JAK1 | 0.95343287 |
| 55 | JAK2 | 0.94506029 |
| 56 | BMX | 0.92697351 |
| 57 | BMPR1B | 0.90791450 |
| 58 | TESK2 | 0.90219457 |
| 59 | PRPF4B | 0.87469485 |
| 60 | CSF1R | 0.87293564 |
| 61 | ITK | 0.86424874 |
| 62 | KSR2 | 0.86060392 |
| 63 | MAP3K1 | 0.84772843 |
| 64 | BTK | 0.84374983 |
| 65 | MUSK | 0.83858566 |
| 66 | NME1 | 0.83271796 |
| 67 | DMPK | 0.82664791 |
| 68 | MST4 | 0.81903005 |
| 69 | MAPKAPK3 | 0.79315920 |
| 70 | PTK2 | 0.77998978 |
| 71 | IKBKB | 0.75308007 |
| 72 | RIPK4 | 0.75062472 |
| 73 | ERBB4 | 0.74827625 |
| 74 | ADRBK1 | 0.73850240 |
| 75 | TTN | 0.73800154 |
| 76 | CDK12 | 0.73231676 |
| 77 | MET | 0.72480615 |
| 78 | TLK1 | 0.71413009 |
| 79 | NME2 | 0.70207763 |
| 80 | HIPK2 | 0.67896715 |
| 81 | HCK | 0.67849937 |
| 82 | MTOR | 0.66910358 |
| 83 | MAP3K7 | 0.64645660 |
| 84 | MAP3K2 | 0.64306112 |
| 85 | STK11 | 0.62181221 |
| 86 | PRKAA2 | 0.62085058 |
| 87 | TGFBR2 | 0.61426594 |
| 88 | KDR | 0.61309495 |
| 89 | * PRKD1 | 0.60748367 |
| 90 | CAMK1D | 0.60016320 |
| 91 | IRAK2 | 0.59569421 |
| 92 | FGR | 0.59019722 |
| 93 | DAPK3 | 0.58190225 |
| 94 | PRKCI | 0.57233742 |
| 95 | LCK | 0.56433027 |
| 96 | JAK3 | 0.55537644 |
| 97 | STK39 | 0.54241386 |
| 98 | ARAF | 0.53618703 |
| 99 | GSK3A | 0.52249908 |
| 100 | * PDPK1 | 0.52234390 |
| 101 | EPHB2 | 0.51711393 |
| 102 | ADRBK2 | 0.51152420 |
| 103 | ABL2 | 0.51104587 |
| 104 | MARK2 | 0.50223329 |
| 105 | MAP3K13 | 0.50179118 |
| 106 | SYK | 0.49985584 |
| 107 | EPHA4 | 0.49818756 |
| 108 | MAPK4 | 0.49796956 |
| 109 | MAP2K3 | 0.48277914 |
| 110 | IRAK4 | 0.48095895 |
| 111 | MATK | 0.47392786 |
| 112 | PRKD2 | 0.45065485 |
| 113 | PAK4 | 0.44972136 |
| 114 | MAPKAPK2 | 0.44774103 |
| 115 | PDK1 | 0.43943405 |
| 116 | PKN1 | 0.43924207 |
| 117 | EPHA2 | 0.43267797 |
| 118 | MAP3K8 | 0.43104758 |
| 119 | CDK4 | 0.42705862 |
| 120 | CSNK1A1L | 0.42380356 |
| 121 | AKT2 | 0.42297136 |
| 122 | GRK5 | 0.40981889 |
| 123 | MAP2K1 | 0.40917076 |
| 124 | SIK3 | 0.38409643 |
| 125 | PRKCH | 0.38144599 |
| 126 | PAK6 | 0.37946036 |
| 127 | ERBB2 | 0.37303271 |
| 128 | OXSR1 | 0.37026579 |
| 129 | PRKG2 | 0.36555837 |
| 130 | BRAF | 0.36502967 |
| 131 | FRK | 0.36329127 |
| 132 | PAK2 | 0.36108192 |
| 133 | DAPK1 | 0.35909904 |
| 134 | EGFR | 0.35301990 |
| 135 | RPS6KA1 | 0.34898057 |
| 136 | PRKACG | 0.33782337 |
| 137 | PRKCZ | 0.33729062 |
| 138 | RPS6KA4 | 0.33525284 |
| 139 | WNK1 | 0.32959824 |
| 140 | MAPK8 | 0.32433275 |
| 141 | NTRK3 | 0.31415005 |
| 142 | TYRO3 | 0.31196664 |
| 143 | RPS6KA2 | 0.30638398 |
| 144 | TAF1 | 0.29291264 |
| 145 | CHEK2 | 0.27464697 |
| 146 | AURKA | 0.27273980 |
| 147 | PINK1 | 0.25478156 |
| 148 | CAMKK1 | 0.25148927 |
| 149 | CDK5 | 0.24715493 |
| 150 | MAP2K6 | 0.24041055 |
| 151 | CDK19 | 0.23403111 |
| 152 | CSNK1D | 0.20142530 |
| 153 | CAMK2B | 0.18317589 |
| 154 | RPS6KA6 | 0.17728176 |
| 155 | PAK1 | 0.17631680 |
| 156 | RPS6KC1 | 0.17568918 |
| 157 | RPS6KL1 | 0.17568918 |
| 158 | MAPK12 | 0.16882940 |
| 159 | CDK11A | 0.16380015 |
| 160 | CDK15 | 0.16156180 |
| 161 | CDC42BPA | 0.12993691 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.58749389 |
| 2 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 3.42417272 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.08292478 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.94167749 |
| 5 | Nicotine addiction_Homo sapiens_hsa05033 | 2.79753038 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.66742013 |
| 7 | Phototransduction_Homo sapiens_hsa04744 | 2.51306980 |
| 8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.50783878 |
| 9 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.50199870 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.41871041 |
| 11 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.41005892 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.39988959 |
| 13 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.39921743 |
| 14 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.38808030 |
| 15 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.32197647 |
| 16 | Histidine metabolism_Homo sapiens_hsa00340 | 2.26889595 |
| 17 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.25392435 |
| 18 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.17994174 |
| 19 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.17514659 |
| 20 | Taste transduction_Homo sapiens_hsa04742 | 2.01760552 |
| 21 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.98576758 |
| 22 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.91877583 |
| 23 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.89414566 |
| 24 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.88255108 |
| 25 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.84483673 |
| 26 | Peroxisome_Homo sapiens_hsa04146 | 1.82213398 |
| 27 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.77164033 |
| 28 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.74623823 |
| 29 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.73299564 |
| 30 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.70979950 |
| 31 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.68550579 |
| 32 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.66054386 |
| 33 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.63060776 |
| 34 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.59671817 |
| 35 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.55257096 |
| 36 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.52831985 |
| 37 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.50552226 |
| 38 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.50278209 |
| 39 | Sulfur relay system_Homo sapiens_hsa04122 | 1.45729442 |
| 40 | Morphine addiction_Homo sapiens_hsa05032 | 1.40983199 |
| 41 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.40372060 |
| 42 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.38633887 |
| 43 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.36205090 |
| 44 | Bile secretion_Homo sapiens_hsa04976 | 1.35567314 |
| 45 | ABC transporters_Homo sapiens_hsa02010 | 1.33567694 |
| 46 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.33005929 |
| 47 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.22343763 |
| 48 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.21722075 |
| 49 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.21285551 |
| 50 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.15501563 |
| 51 | Retinol metabolism_Homo sapiens_hsa00830 | 1.15383010 |
| 52 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.15165056 |
| 53 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.13825914 |
| 54 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.13605164 |
| 55 | GABAergic synapse_Homo sapiens_hsa04727 | 1.12899490 |
| 56 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.11930368 |
| 57 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.05197169 |
| 58 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.05000543 |
| 59 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.03375618 |
| 60 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.01618602 |
| 61 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.00333508 |
| 62 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.99374218 |
| 63 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.98324836 |
| 64 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.96407565 |
| 65 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.94188702 |
| 66 | Lysine degradation_Homo sapiens_hsa00310 | 0.93241973 |
| 67 | Carbon metabolism_Homo sapiens_hsa01200 | 0.91554267 |
| 68 | Other glycan degradation_Homo sapiens_hsa00511 | 0.91014813 |
| 69 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.90815318 |
| 70 | Lysosome_Homo sapiens_hsa04142 | 0.89059454 |
| 71 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.87236011 |
| 72 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.86097808 |
| 73 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.84022386 |
| 74 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.82812825 |
| 75 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.76675770 |
| 76 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.74695672 |
| 77 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.73975774 |
| 78 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.73849311 |
| 79 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.72160429 |
| 80 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.71864643 |
| 81 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.70234658 |
| 82 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.69389232 |
| 83 | * Calcium signaling pathway_Homo sapiens_hsa04020 | 0.69235942 |
| 84 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.68778520 |
| 85 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.63978149 |
| 86 | Melanogenesis_Homo sapiens_hsa04916 | 0.62281177 |
| 87 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.62195120 |
| 88 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.61101265 |
| 89 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.60748670 |
| 90 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.58559521 |
| 91 | Insulin secretion_Homo sapiens_hsa04911 | 0.57159805 |
| 92 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.56562819 |
| 93 | Insulin resistance_Homo sapiens_hsa04931 | 0.53901057 |
| 94 | Prion diseases_Homo sapiens_hsa05020 | 0.53467686 |
| 95 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.52809189 |
| 96 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.52558998 |
| 97 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.50984881 |
| 98 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.50880797 |
| 99 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.49996703 |
| 100 | Pertussis_Homo sapiens_hsa05133 | 0.48429948 |
| 101 | Galactose metabolism_Homo sapiens_hsa00052 | 0.48239961 |
| 102 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.47006688 |
| 103 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.46528340 |
| 104 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.45459434 |
| 105 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.43433712 |
| 106 | Mineral absorption_Homo sapiens_hsa04978 | 0.43099247 |
| 107 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.41826671 |
| 108 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.41287182 |
| 109 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.40424954 |
| 110 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.40183950 |
| 111 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.40030098 |
| 112 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.39665630 |
| 113 | Circadian entrainment_Homo sapiens_hsa04713 | 0.38520997 |
| 114 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.37116669 |
| 115 | Cocaine addiction_Homo sapiens_hsa05030 | 0.37050766 |
| 116 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.36753770 |
| 117 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.36546225 |
| 118 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.36088276 |
| 119 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.35929503 |
| 120 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.35722367 |
| 121 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.35080736 |
| 122 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.34284011 |
| 123 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.33263932 |
| 124 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.32992949 |
| 125 | Leishmaniasis_Homo sapiens_hsa05140 | 0.32723837 |
| 126 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.31153984 |
| 127 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.30644574 |
| 128 | Hepatitis C_Homo sapiens_hsa05160 | 0.30537950 |
| 129 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.28899646 |
| 130 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.27234909 |
| 131 | Bladder cancer_Homo sapiens_hsa05219 | 0.26968388 |
| 132 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.25747624 |
| 133 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.23206892 |
| 134 | Long-term potentiation_Homo sapiens_hsa04720 | 0.22145749 |
| 135 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.21917283 |
| 136 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.21807785 |
| 137 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.20552749 |
| 138 | Salivary secretion_Homo sapiens_hsa04970 | 0.19570757 |
| 139 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.19560803 |
| 140 | Amoebiasis_Homo sapiens_hsa05146 | 0.18819131 |
| 141 | * Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.17078937 |
| 142 | Legionellosis_Homo sapiens_hsa05134 | 0.16867940 |
| 143 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.15183905 |
| 144 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.13071834 |
| 145 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.10177243 |
| 146 | * Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.10082166 |

